HOLLY WOOSLEY: Open Payments
NPI 1568087625 · CHARLESTOWN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,892 in 171 payments from 18 companies in 2025. Trend: 2023 $2,151 · 2024 $3,393 · 2025 $5,892
Food & beverage: $2,871Consulting: $2,849Education: $111Travel & lodging: $61
| Company | Payments | Amount |
|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 6 | $2,967 |
| ABBVIE INC. | 22 | $600 |
| Alkermes, Inc. | 37 | $448 |
| Teva Pharmaceuticals USA, Inc. | 18 | $374 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 21 | $341 |
| Otsuka America Pharmaceutical, Inc. | 24 | $323 |
| Tris Pharma Inc | 6 | $120 |
| Vanda Pharmaceuticals Inc. | 6 | $119 |
| Janssen Pharmaceuticals, Inc | 5 | $111 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $107 |
Products named: REJOYN, VRAYLAR, CAPLYTA, ARISTADA, REXULTI, UZEDY, LYBALVI, Dyanavel XR.
Industry payments across IN — which companies pay providers there.
